Cargando…

Vitamin D as a Potential Therapeutic Target and Prognostic Marker for Colorectal Cancer

Detalles Bibliográficos
Autor principal:	Bintintan, Vasile V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6013779/ https://www.ncbi.nlm.nih.gov/pubmed/29724656 http://dx.doi.org/10.1016/j.ebiom.2018.04.015

Ejemplares similares

The Role of Vitamin D as a Prognostic Marker in Papillary Thyroid Cancer
por: Bains, Ashank, et al.
Publicado: (2021)

PPM1D is a prognostic marker and therapeutic target in colorectal cancer
por: PENG, TIAN-SHU, et al.
Publicado: (2014)

Moving miRNAs to therapeutic targets in colorectal cancer
por: McGregor, Mark, et al.
Publicado: (2019)

Cdc7 overexpression is an independent prognostic marker and a potential therapeutic target in colorectal cancer
por: Melling, Nathaniel, et al.
Publicado: (2015)

Calnexin, an ER-induced protein, is a prognostic marker and potential therapeutic target in colorectal cancer
por: Ryan, Deborah, et al.
Publicado: (2016)

Vitamin D status in critical care: Contributor or marker of poor health?
por: Amrein, Karin
Publicado: (2014)

Plasma exosome-derived circGAPVD1 as a potential diagnostic marker for colorectal cancer
por: Li, Tiankang, et al.
Publicado: (2023)

Vitamin D for COVID-19 on Trial: An Update on Prevention and Therapeutic Application
por: Grant, William B., et al.
Publicado: (2021)

Personalising cancer medicine with prognostic markers
por: Kerr, David J, et al.
Publicado: (2021)

Transgelin in bladder cancer: A potential biomarker and therapeutic target
por: Li, Wei-Ming, et al.
Publicado: (2019)

Vitamin D supplementation: a potential therapeutic agent for metastatic colorectal cancer
por: Yuan, Chen, et al.
Publicado: (2020)

Erratum to: Calnexin, an ER stress-induced protein, is a prognostic marker and potential therapeutic target in colorectal cancer
por: Ryan, Deborah, et al.
Publicado: (2016)

Screening of potential diagnostic markers and therapeutic targets against colorectal cancer
por: Tian, XiaoQing, et al.
Publicado: (2015)

Therapeutic Implications of the Immunoscore in Patients with Colorectal Cancer
por: El Sissy, Carine, et al.
Publicado: (2021)

Serum vitamin D receptor (VDR) levels as a potential diagnostic marker for colorectal cancer
por: Al-Ghafari, Ayat B., et al.
Publicado: (2020)

Approaching the challenges of MKK3/p38delta MAPK targeting for therapeutic purpose in colorectal cancer
por: Stramucci, Lorenzo, et al.
Publicado: (2019)

Ghrelin is a prognostic marker and a potential therapeutic target in breast cancer
por: Grönberg, Malin, et al.
Publicado: (2017)

Immunomodulatory and therapeutic implications of vitamin D in the management of COVID-19
por: Dhawan, Manish, et al.
Publicado: (2022)

Vitamin D deficiency in breastfed infants & the need for routine vitamin D supplementation
por: Balasubramanian, S.
Publicado: (2011)

Wnt-11 as a Potential Prognostic Biomarker and Therapeutic Target in Colorectal Cancer
por: Gorroño-Etxebarria, Irantzu, et al.
Publicado: (2019)

Galectins as New Prognostic Markers and Potential Therapeutic Targets for Advanced Prostate Cancers
por: Laderach, Diego J., et al.
Publicado: (2013)

DLC-1 is an independent prognostic marker and potential therapeutic target in hepatocellular cancer
por: Song, L. J., et al.
Publicado: (2016)

Determination of Potential Therapeutic Targets and Prognostic Markers of Ovarian Cancer by Bioinformatics Analysis
por: Zhang, Jing, et al.
Publicado: (2021)

Bilirubin: A Potential Biomarker and Therapeutic Target for Diabetic Nephropathy
por: Hull, Travis D., et al.
Publicado: (2014)

Beta-2 Agonism: A Potential Therapeutic Target for Dyslipidemia
por: Davidson, Michael H.
Publicado: (2015)

Vitamin D and diabetes mellitus
por: Nuri Aydin, Fevzi, et al.
Publicado: (2014)

Live Longer with Vitamin D?
por: Gröber, Uwe, et al.
Publicado: (2015)

In Pursuit of Vitamin D in Plants
por: Black, Lucinda J., et al.
Publicado: (2017)

Vitamin D and COVID-19
por: Trovas, George, et al.
Publicado: (2020)

Energy metabolism pathways in breast cancer progression: The reprogramming, crosstalk, and potential therapeutic targets
por: Zheng, Xuewei, et al.
Publicado: (2022)

Optimizing Vitamin D Concentrations for Breast Cancer Risk Reduction
por: Stearns, Vered, et al.
Publicado: (2013)

αTAT1: a potential therapeutic target in cancer?
por: Chien, J-Y, et al.
Publicado: (2016)

Vitamin D is a prognostic marker in heart failure
Publicado: (2010)

BRG1 Is a Prognostic Marker and Potential Therapeutic Target in Human Breast Cancer
por: Bai, Jin, et al.
Publicado: (2013)

Identifying genes that regulate bone remodeling as potential therapeutic targets
por: Krane, Stephen M.
Publicado: (2005)

SMARCD3 is a potential prognostic marker and therapeutic target in CAFs
por: Jiang, Ming, et al.
Publicado: (2020)

Developments in the Role of Endothelin-1 in Atherosclerosis: A Potential Therapeutic Target?
por: Sutton, Greg, et al.
Publicado: (2019)

Extravesicular TIMP-1 is a non-invasive independent prognostic marker and potential therapeutic target in colorectal liver metastases
por: Rao, Venkatesh Sadananda, et al.
Publicado: (2022)

Vitamin D and Chronic Kidney Disease
por: Kostoglou-Athanassiou, Ifigenia
Publicado: (2021)

Therapeutic potential of CDK11 in cancer
por: Blazek, Dalibor
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j8s7g1162vq864s5nhcbus50na